Bicara Therapeutics CMO Executes Rule 10b5-1 Trading Plan Involving Share Sales and Option Exercises
David Raben, the Chief Medical Officer of Bicara Therapeutics Inc. (NASDAQ: BCAX), has completed a series of transactions involving both the sale of common stock and the exercise of stock options. These moves were conducted under a pre-arranged Rule 10b5-1 trading plan established on February 12, 2025. The transaction activity occurred on April 27,…